Michael Best is pleased to announce that Mark Yacura has joined the firm’s Washington, D.C. office as partner and will focus his practice FDA Regulatory matters. Previously, Yacura was a partner at Quarles & Brady LLP.
With more than 30 years of experience, Yacura provides counsel and representation to his clients on a wide breadth of Food and Drug Administration (FDA)-related matters in connection with synthetic pharmaceuticals, biotechnology, diagnostics, medical devices, conventional foods, dietary supplements, and cosmetics. He regularly advises clients on the FDA approval and clearance process, regulatory compliance and enforcement issues, labeling, manufacturing and advertising claims and substantiation, due diligence, securities filings, collaboration licensing, and supply and clinical trial agreements, among other related matters.
“The knowledge and experience Mark gathered while serving in the FDA will play a pivotal role as we continue to help our foreign and domestic clients navigate the complex and ever-changing political landscape,” said Eric Callisto, Group Chair of Michael Best’s Regulatory Practice. “He is highly respected among his colleagues and clients, and it’s an honor to welcome him to our team in the Beltway.”
In addition to his extensive work with the FDA, Yacura also handles matters before several other administrative agencies. This includes the Consumer Product Safety Commission, the Environmental Protection Agency, the Federal Trade Commission, and the National Advertising Division of the Better Business Bureau.
Yacura earned his J.D., cum laude, from the American University Washington College of Law, his M.B.A. from the University of Pittsburgh, and his B.S. in Pharmacy from Duquesne University.